Global Hemostatic Gel Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Hemostatic Gel Market
Hemostatic gel is used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.In recent years, global hemostatic gels have developed rapidly, with an average growth rate of around 7%.In 2018, global production of hemostatic gels was about 3.26 million pieces.In 2018, China accounted for about 3 percent of global sales.In the next five years, China's hemostatic gel products will continue to grow rapidly.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Baxter, J&J, CryoLife, Integra Life Sciences are major suppliers.These suppliers have mastered key technologies and patents, and have a fixed customer base, which has formed a monopoly situation in the market.The growth of the elderly population and the increasing prevalence of chronic diseases are the driving factors affecting the industry.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually led to surgery, which in turn spurred the development of the hemostatic gel industry.

Due to the COVID-19 pandemic, the global Hemostatic Gel market size is estimated to be worth US$ 1000.8 million in 2022 and is forecast to a readjusted size of US$ 1356.5 million by 2028 with a CAGR of 5.2% during the review period. Fully considering the economic change by this health crisis, Fibrin accounting for % of the Hemostatic Gel global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Minimally Invasive Surgery segment is altered to an % CAGR throughout this forecast period.

Global Hemostatic Gel key players include Baxter, J&J, Advance Medical Solution, etc. Global top three manufacturers hold a share over 45%.

North America is the largest market, with a share over 60%, followed by Europe, with a share over 20 percent.

In terms of product, Fibrin is the largest segment, with a share over 35%. And in terms of application, the largest application is Minimally Invasive Surgery, followed by General Surgery, etc.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

Fibrin

Gelatin

Other

Segment by Application

Minimally Invasive Surgery

General Surgery

Others

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Hemostatic Gel market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Baxter

J&J

CryoLife

Integra Life Sciences

Advance Medical Solution

BD

CSL Behring

Pfizer

B Braun

TABLE OF CONTENT

1 Study Coverage
1.1 Hemostatic Gel Product Introduction

1.2 Market by Type

1.2.1 Global Hemostatic Gel Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Fibrin

1.2.3 Gelatin

1.2.4 Other

1.3 Market by Application

1.3.1 Global Hemostatic Gel Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Minimally Invasive Surgery

1.3.3 General Surgery

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Hemostatic Gel Sales Estimates and Forecasts 2017-2028

2.2 Global Hemostatic Gel Revenue Estimates and Forecasts 2017-2028

2.3 Global Hemostatic Gel Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Hemostatic Gel Sales by Region

2.4.1 Global Hemostatic Gel Sales by Region (2017-2022)

2.4.2 Global Sales Hemostatic Gel by Region (2023-2028)

2.5 Global Hemostatic Gel Revenue by Region

2.5.1 Global Hemostatic Gel Revenue by Region (2017-2022)

2.5.2 Global Hemostatic Gel Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Hemostatic Gel Sales by Manufacturers

3.1.1 Global Top Hemostatic Gel Manufacturers by Sales (2017-2022)

3.1.2 Global Hemostatic Gel Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hemostatic Gel in 2021

3.2 Global Hemostatic Gel Revenue by Manufacturers

3.2.1 Global Hemostatic Gel Revenue by Manufacturers (2017-2022)

3.2.2 Global Hemostatic Gel Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Hemostatic Gel Revenue in 2021

3.3 Global Hemostatic Gel Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Hemostatic Gel Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Hemostatic Gel Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Hemostatic Gel Sales by Type

4.1.1 Global Hemostatic Gel Historical Sales by Type (2017-2022)

4.1.2 Global Hemostatic Gel Forecasted Sales by Type (2023-2028)

4.1.3 Global Hemostatic Gel Sales Market Share by Type (2017-2028)

4.2 Global Hemostatic Gel Revenue by Type

4.2.1 Global Hemostatic Gel Historical Revenue by Type (2017-2022)

4.2.2 Global Hemostatic Gel Forecasted Revenue by Type (2023-2028)

4.2.3 Global Hemostatic Gel Revenue Market Share by Type (2017-2028)

4.3 Global Hemostatic Gel Price by Type

4.3.1 Global Hemostatic Gel Price by Type (2017-2022)

4.3.2 Global Hemostatic Gel Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Hemostatic Gel Sales by Application

5.1.1 Global Hemostatic Gel Historical Sales by Application (2017-2022)

5.1.2 Global Hemostatic Gel Forecasted Sales by Application (2023-2028)

5.1.3 Global Hemostatic Gel Sales Market Share by Application (2017-2028)

5.2 Global Hemostatic Gel Revenue by Application

5.2.1 Global Hemostatic Gel Historical Revenue by Application (2017-2022)

5.2.2 Global Hemostatic Gel Forecasted Revenue by Application (2023-2028)

5.2.3 Global Hemostatic Gel Revenue Market Share by Application (2017-2028)

5.3 Global Hemostatic Gel Price by Application

5.3.1 Global Hemostatic Gel Price by Application (2017-2022)

5.3.2 Global Hemostatic Gel Price Forecast by Application (2023-2028)

6 North America

6.1 North America Hemostatic Gel Market Size by Type

6.1.1 North America Hemostatic Gel Sales by Type (2017-2028)

6.1.2 North America Hemostatic Gel Revenue by Type (2017-2028)

6.2 North America Hemostatic Gel Market Size by Application

6.2.1 North America Hemostatic Gel Sales by Application (2017-2028)

6.2.2 North America Hemostatic Gel Revenue by Application (2017-2028)

6.3 North America Hemostatic Gel Market Size by Country

6.3.1 North America Hemostatic Gel Sales by Country (2017-2028)

6.3.2 North America Hemostatic Gel Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Hemostatic Gel Market Size by Type

7.1.1 Europe Hemostatic Gel Sales by Type (2017-2028)

7.1.2 Europe Hemostatic Gel Revenue by Type (2017-2028)

7.2 Europe Hemostatic Gel Market Size by Application

7.2.1 Europe Hemostatic Gel Sales by Application (2017-2028)

7.2.2 Europe Hemostatic Gel Revenue by Application (2017-2028)

7.3 Europe Hemostatic Gel Market Size by Country

7.3.1 Europe Hemostatic Gel Sales by Country (2017-2028)

7.3.2 Europe Hemostatic Gel Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Hemostatic Gel Market Size by Type

8.1.1 Asia Pacific Hemostatic Gel Sales by Type (2017-2028)

8.1.2 Asia Pacific Hemostatic Gel Revenue by Type (2017-2028)

8.2 Asia Pacific Hemostatic Gel Market Size by Application

8.2.1 Asia Pacific Hemostatic Gel Sales by Application (2017-2028)

8.2.2 Asia Pacific Hemostatic Gel Revenue by Application (2017-2028)

8.3 Asia Pacific Hemostatic Gel Market Size by Region

8.3.1 Asia Pacific Hemostatic Gel Sales by Region (2017-2028)

8.3.2 Asia Pacific Hemostatic Gel Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 China Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

9 Latin America

9.1 Latin America Hemostatic Gel Market Size by Type

9.1.1 Latin America Hemostatic Gel Sales by Type (2017-2028)

9.1.2 Latin America Hemostatic Gel Revenue by Type (2017-2028)

9.2 Latin America Hemostatic Gel Market Size by Application

9.2.1 Latin America Hemostatic Gel Sales by Application (2017-2028)

9.2.2 Latin America Hemostatic Gel Revenue by Application (2017-2028)

9.3 Latin America Hemostatic Gel Market Size by Country

9.3.1 Latin America Hemostatic Gel Sales by Country (2017-2028)

9.3.2 Latin America Hemostatic Gel Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Hemostatic Gel Market Size by Type

10.1.1 Middle East and Africa Hemostatic Gel Sales by Type (2017-2028)

10.1.2 Middle East and Africa Hemostatic Gel Revenue by Type (2017-2028)

10.2 Middle East and Africa Hemostatic Gel Market Size by Application

10.2.1 Middle East and Africa Hemostatic Gel Sales by Application (2017-2028)

10.2.2 Middle East and Africa Hemostatic Gel Revenue by Application (2017-2028)

10.3 Middle East and Africa Hemostatic Gel Market Size by Country

10.3.1 Middle East and Africa Hemostatic Gel Sales by Country (2017-2028)

10.3.2 Middle East and Africa Hemostatic Gel Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Baxter

11.1.1 Baxter Corporation Information

11.1.2 Baxter Overview

11.1.3 Baxter Hemostatic Gel Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Baxter Hemostatic Gel Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Baxter Recent Developments

11.2 J&J

11.2.1 J&J Corporation Information

11.2.2 J&J Overview

11.2.3 J&J Hemostatic Gel Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 J&J Hemostatic Gel Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 J&J Recent Developments

11.3 CryoLife

11.3.1 CryoLife Corporation Information

11.3.2 CryoLife Overview

11.3.3 CryoLife Hemostatic Gel Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 CryoLife Hemostatic Gel Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 CryoLife Recent Developments

11.4 Integra Life Sciences

11.4.1 Integra Life Sciences Corporation Information

11.4.2 Integra Life Sciences Overview

11.4.3 Integra Life Sciences Hemostatic Gel Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Integra Life Sciences Hemostatic Gel Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Integra Life Sciences Recent Developments

11.5 Advance Medical Solution

11.5.1 Advance Medical Solution Corporation Information

11.5.2 Advance Medical Solution Overview

11.5.3 Advance Medical Solution Hemostatic Gel Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Advance Medical Solution Hemostatic Gel Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Advance Medical Solution Recent Developments

11.6 BD

11.6.1 BD Corporation Information

11.6.2 BD Overview

11.6.3 BD Hemostatic Gel Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 BD Hemostatic Gel Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 BD Recent Developments

11.7 CSL Behring

11.7.1 CSL Behring Corporation Information

11.7.2 CSL Behring Overview

11.7.3 CSL Behring Hemostatic Gel Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 CSL Behring Hemostatic Gel Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 CSL Behring Recent Developments

11.8 Pfizer

11.8.1 Pfizer Corporation Information

11.8.2 Pfizer Overview

11.8.3 Pfizer Hemostatic Gel Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 Pfizer Hemostatic Gel Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Pfizer Recent Developments

11.9 B Braun

11.9.1 B Braun Corporation Information

11.9.2 B Braun Overview

11.9.3 B Braun Hemostatic Gel Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 B Braun Hemostatic Gel Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 B Braun Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Hemostatic Gel Industry Chain Analysis

12.2 Hemostatic Gel Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Hemostatic Gel Production Mode & Process

12.4 Hemostatic Gel Sales and Marketing

12.4.1 Hemostatic Gel Sales Channels

12.4.2 Hemostatic Gel Distributors

12.5 Hemostatic Gel Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Hemostatic Gel Industry Trends

13.2 Hemostatic Gel Market Drivers

13.3 Hemostatic Gel Market Challenges

13.4 Hemostatic Gel Market Restraints

14 Key Findings in The Global Hemostatic Gel Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample